FDA's Bad Labeling Could Lead to Job Cuts - Tobinco CEO
Tobinco is considering job cuts but others are hiring! Check it out! (Isn't it tempting?)
Chief Executive Officer of Tobinco Pharmaceutical Group of Companies, Mr Samuel Amo Tobin, has revealed that the Food and Drug Authority’s (FDA) bad labeling of the company could lead to job cuts in future. According to him, the bad press has affected the company and admitted may eventually lead to laying-off some of its employees. “We have been hit seriously and we do not know what is even going to happen on our staff.
Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)
Chief Executive Officer of Tobinco Pharmaceutical Group of Companies, Mr Samuel Amo Tobin, has revealed that the Food and Drug Authority’s (FDA) bad labeling of the company could lead to job cuts in future. According to him, the bad press has affected the company and admitted may eventually lead to laying-off some of its employees. “We have been hit seriously and we do not know what is even going to happen on our staff.
Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)